-transparent.png){kind=logo}
High dose methotrexate followed by citrovorum factor reversal has been utilized in twenty-six patients with advanced cancer. Four of 10 patients with head and neck cancer had an objective response. One of 7 patients with metastatic osteosarcoma to the lungs had stabilization with twenty treatments over 23 months. One patient with acute lymphocytic leukemia developed marrow aplasia but did not attain remission. The regimen was well tolerated when meticulous attention was paid to hydration, urine alkalinization, renal function and third space fluid accumulation. Life-threatening or lethal toxicity was encountered when these phenomena were not scrupulously observed.
Related Publications
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
December 1977,
Cancer treatment reports,
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
December 1977,
Cancer,
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
September 1980,
Harefuah,
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
January 1978,
Cancer chemotherapy and pharmacology,
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
December 1980,
The Journal of the Maine Medical Association,
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
June 1990,
Gynecologic oncology,
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
January 1980,
Therapeutic drug monitoring,
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
August 1984,
Onkologie,
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
June 1985,
Cancer,
E P Ambinder, and
M Perloff, and
T Ohnuma, and
H F Biller, and
J F Holland
October 1979,
Cancer research,
